News from the healthcare data industry
Pharma trailblazer will accelerate growth at COTA with a focus on advancing real-world data use in drug development, increasing diversity in clinical trials, and supporting the move to data-driven, value-based...
Abstract The landscape for evidence generation in hematologic malignancies is rapidly evolving. While randomized controlled trials (RCTs) remain the gold standard in support of drug efficacy, approval and use, the...
December 16, 2021 COTA Team Majority of providers also believe all cancer clinical trials should include real-world data to ensure diverse representation in treatments. COTA announced insights from a study...
November 11, 2021 COTA Team New hire joins COTA following seven year tenure at FDA COTA, Inc., an oncology real-world data and analytics company, today announced that a new strategic hire...